28412969|t|Engagement of cellular prion protein with the co-chaperone Hsp70 / 90 organizing protein regulates the proliferation of glioblastoma stem-like cells
28412969|a|Glioblastoma (GBM), a highly aggressive brain tumor, contains a subpopulation of glioblastoma stem-like cells (GSCs) that play roles in tumor maintenance, invasion, and therapeutic resistance. GSCs are therefore a promising target for GBM treatment. Our group identified the cellular prion protein (PrP(C)) and its partner, the co-chaperone Hsp70 / 90 organizing protein (HOP), as potential target candidates due to their role in GBM tumorigenesis and in neural stem cell maintenance. GSCs expressing different levels of PrP(C) were cultured as neurospheres with growth factors, and characterized with stem cells markers and adhesion molecules markers through immunofluorescence and flow cytometry. We than evaluated GSC self-renewal and proliferation by clonal density assays and BrdU incorporation, respectively, in front of recombinant HOP treatment, combined or not with a HOP peptide which mimics the PrP(C) binding site. Stable silencing of HOP was also performed in parental and/or PrP(C) -depleted cell populations, and proliferation in vitro and tumor growth in vivo were evaluated. Migration assays were performed on laminin-1 pre-coated glass. We observed that, when GBM cells are cultured as neurospheres, they express specific stemness markers such as CD133, CD15, Oct4, and SOX2; PrP(C) is upregulated compared to monolayer culture and co-localizes with CD133. PrP(C) silencing downregulates the expression of molecules associated with cancer stem cells, upregulates markers of cell differentiation and affects GSC self-renewal, pointing to a pivotal role for PrP(C) in the maintenance of GSCs. Exogenous HOP treatment increases proliferation and self-renewal of GSCs in a PrP(C) -dependent manner while HOP knockdown disturbs the proliferation process. In vivo, PrP(C) and/or HOP knockdown potently inhibits the growth of subcutaneously implanted glioblastoma cells. In addition, disruption of the PrP(C) - HOP complex by a HOP peptide, which mimics the PrP(C) binding site, affects GSC self-renewal and proliferation indicating that the HOP - PrP(C) complex is required for GSC stemness. Furthermore, PrP(C) -depleted GSCs downregulate cell adhesion-related proteins and impair cell migration indicating a putative role for PrP(C) in the cell surface stability of cell adhesion molecules and GBM cell invasiveness, respectively. In conclusion, our results show that the modulation of HOP - PrP(C) engagement or the decrease of PrP(C) and HOP expression may represent a potential therapeutic intervention in GBM, regulating glioblastoma stem-like cell self-renewal, proliferation, and migration.
28412969	14	36	cellular prion protein	T116	C0074202
28412969	46	58	co-chaperone	T116,T123	C0243041
28412969	59	64	Hsp70	T116,T123	C0243043
28412969	59	88	Hsp70 / 90 organizing protein	T116,T123	C0018850
28412969	67	69	90	T116,T123	C0243044
28412969	103	116	proliferation	T043	C0596290
28412969	120	132	glioblastoma	T191	C0017636
28412969	120	148	glioblastoma stem-like cells	T025	C0007634
28412969	149	161	Glioblastoma	T191	C0017636
28412969	163	166	GBM	T191	C0017636
28412969	189	200	brain tumor	T191	C0006118
28412969	230	242	glioblastoma	T191	C0017636
28412969	230	258	glioblastoma stem-like cells	T025	C0007634
28412969	260	264	GSCs	T025	C0007634
28412969	285	290	tumor	T191	C0027651
28412969	291	302	maintenance	T052	C0024501
28412969	304	312	invasion	T046	C0027626
28412969	318	340	therapeutic resistance	T038	C0013203
28412969	342	346	GSCs	T025	C0007634
28412969	373	379	target	T169	C1521840
28412969	384	387	GBM	T191	C0017636
28412969	388	397	treatment	T169	C1522326
28412969	424	446	cellular prion protein	T116	C0074202
28412969	448	454	PrP(C)	T116	C0074202
28412969	477	489	co-chaperone	T116,T123	C0243041
28412969	490	495	Hsp70	T116,T123	C0243043
28412969	490	519	Hsp70 / 90 organizing protein	T116,T123	C0018850
28412969	498	500	90	T116,T123	C0243044
28412969	521	524	HOP	T116,T123	C0018850
28412969	540	546	target	T169	C1521840
28412969	579	582	GBM	T191	C0017636
28412969	583	596	tumorigenesis	T191	C0596263
28412969	604	620	neural stem cell	T025	C1113654
28412969	634	638	GSCs	T025	C0007634
28412969	670	676	PrP(C)	T116	C0074202
28412969	682	690	cultured	T059	C0007585
28412969	694	706	neurospheres	T025	C0007634
28412969	712	726	growth factors	T116,T123	C0018284
28412969	751	761	stem cells	T025	C0038250
28412969	762	769	markers	T086	C0012872
28412969	774	800	adhesion molecules markers	T086	C0012872
28412969	809	827	immunofluorescence	T059	C0079603
28412969	832	846	flow cytometry	T059	C0016263
28412969	866	869	GSC	T025	C0007634
28412969	870	882	self-renewal	T043	C4042950
28412969	887	900	proliferation	T043	C0596290
28412969	904	925	clonal density assays	T059	C0005507
28412969	930	934	BrdU	T114,T121	C0006233
28412969	930	948	BrdU incorporation	T059	C0022885
28412969	988	991	HOP	T116,T123	C0018850
28412969	992	1001	treatment	T169	C1522326
28412969	1026	1029	HOP	T116,T123	C0018850
28412969	1030	1037	peptide	T116	C0030956
28412969	1055	1061	PrP(C)	T116	C0074202
28412969	1062	1074	binding site	T192	C0005456
28412969	1083	1092	silencing	T045	C0598496
28412969	1096	1099	HOP	T116,T123	C0018850
28412969	1138	1144	PrP(C)	T116	C0074202
28412969	1155	1171	cell populations	T025	C0007634
28412969	1177	1190	proliferation	T043	C0596290
28412969	1191	1199	in vitro	T080	C1533691
28412969	1204	1216	tumor growth	T191	C0598934
28412969	1217	1224	in vivo	T082	C1515655
28412969	1241	1257	Migration assays	T059	C1513300
28412969	1276	1285	laminin-1	T116	C0908936
28412969	1276	1302	laminin-1 pre-coated glass	T073	C0017596
28412969	1327	1330	GBM	T191	C0017636
28412969	1331	1336	cells	T025	C0007634
28412969	1341	1349	cultured	T059	C0007585
28412969	1353	1365	neurospheres	T025	C0007634
28412969	1389	1405	stemness markers	T086	C0012872
28412969	1414	1419	CD133	T116,T123	C0673026
28412969	1421	1425	CD15	T109,T129	C0080188
28412969	1427	1431	Oct4	T116,T123	C0069304
28412969	1437	1441	SOX2	T116,T123	C0300483
28412969	1443	1449	PrP(C)	T116	C0074202
28412969	1477	1494	monolayer culture	T059	C1510803
28412969	1517	1522	CD133	T116,T123	C0673026
28412969	1524	1530	PrP(C)	T116	C0074202
28412969	1531	1540	silencing	T045	C0598496
28412969	1559	1582	expression of molecules	T045	C0017262
28412969	1599	1616	cancer stem cells	T025	C1956422
28412969	1630	1637	markers	T086	C0012872
28412969	1641	1661	cell differentiation	T043	C0007589
28412969	1674	1677	GSC	T025	C0007634
28412969	1678	1690	self-renewal	T043	C4042950
28412969	1723	1729	PrP(C)	T116	C0074202
28412969	1752	1756	GSCs	T025	C0007634
28412969	1768	1771	HOP	T116,T123	C0018850
28412969	1772	1781	treatment	T169	C1522326
28412969	1792	1805	proliferation	T043	C0596290
28412969	1810	1822	self-renewal	T043	C4042950
28412969	1826	1830	GSCs	T025	C0007634
28412969	1836	1842	PrP(C)	T116	C0074202
28412969	1867	1870	HOP	T116,T123	C0018850
28412969	1894	1915	proliferation process	T043	C0596290
28412969	1917	1924	In vivo	T082	C1515655
28412969	1926	1932	PrP(C)	T116	C0074202
28412969	1940	1943	HOP	T116,T123	C0018850
28412969	1963	1971	inhibits	T052	C3463820
28412969	1976	1982	growth	T043	C0007595
28412969	2011	2023	glioblastoma	T191	C0017636
28412969	2024	2029	cells	T025	C0007634
28412969	2062	2068	PrP(C)	T116	C0074202
28412969	2062	2082	PrP(C) - HOP complex	T116,T123	C1180347
28412969	2071	2074	HOP	T116,T123	C0018850
28412969	2088	2091	HOP	T116,T123	C0018850
28412969	2092	2099	peptide	T116	C0030956
28412969	2118	2124	PrP(C)	T116	C0074202
28412969	2125	2137	binding site	T192	C0005456
28412969	2147	2150	GSC	T025	C0007634
28412969	2151	2163	self-renewal	T043	C4042950
28412969	2168	2181	proliferation	T043	C0596290
28412969	2202	2205	HOP	T116,T123	C0018850
28412969	2202	2222	HOP - PrP(C) complex	T116,T123	C1180347
28412969	2208	2214	PrP(C)	T116	C0074202
28412969	2239	2242	GSC	T025	C0007634
28412969	2243	2251	stemness	T080	C0205556
28412969	2266	2272	PrP(C)	T116	C0074202
28412969	2283	2287	GSCs	T025	C0007634
28412969	2301	2305	cell	T025	C0007634
28412969	2306	2331	adhesion-related proteins	T116,T123	C0033684
28412969	2343	2357	cell migration	T043	C1622501
28412969	2389	2395	PrP(C)	T116	C0074202
28412969	2403	2425	cell surface stability	T033	C0243095
28412969	2429	2452	cell adhesion molecules	T116,T123	C0007578
28412969	2457	2460	GBM	T191	C0017636
28412969	2466	2478	invasiveness	T046	C0027626
28412969	2549	2552	HOP	T116,T123	C0018850
28412969	2555	2561	PrP(C)	T116	C0074202
28412969	2592	2598	PrP(C)	T116	C0074202
28412969	2603	2606	HOP	T116,T123	C0018850
28412969	2607	2617	expression	T045	C0017262
28412969	2644	2668	therapeutic intervention	T061	C0808232
28412969	2672	2675	GBM	T191	C0017636
28412969	2688	2700	glioblastoma	T191	C0017636
28412969	2688	2715	glioblastoma stem-like cell	T025	C0007634
28412969	2716	2728	self-renewal	T043	C4042950
28412969	2730	2743	proliferation	T043	C0596290
28412969	2749	2758	migration	T043	C1622501